NOT-DK-23-030: Notice of Change in Eligibility to Part I for RFA-DK-23-001 "A Consortium for Gut-Brain Communication in Parkinsons Disease (U24 Clinical Trial not allowed)"

Notice of Change in Eligibility to Part I for RFA-DK-23-001 "A Consortium for Gut-Brain Communication in Parkinson’s Disease (U24 Clinical Trial not allowed)"

Notice Number:

NOT-DK-23-030

Key Dates

Release Date:

August 22, 2023

Related Announcements

August 1, 2023 - A Consortium for Gut-Brain Communication in Parkinson’s Disease (U24 Clinical Trial not allowed). See NOFO RFA-DK-23-001.

Issued by

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Purpose

The purpose of this Notice is to alert potential applicants to changes in Part I for RFA-DK-23-001 "A Consortium for Gut-Brain Communication in Parkinson’s Disease (U24 Clinical Trial not allowed)". This Notice of Funding Opportunity (NOFO) was issued on 8/1/2023. Changes to the NOFO are shown in bold italics below.

Currently, Reads:

Part 1 Overview Information

Number of Applications: Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility.

Modified to Read:

Part 1 Overview Information

Number of Applications: Applicant organizations may submit more than one application, provided that each application is scientifically distinct as defined in Section III. 3. Additional Information on Eligibility.

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Terez Shea-Donohue, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301 825-2314
Email: [email protected]